Stay updated on Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial
Sign up to get notified when there's something new on the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page.

Latest updates to the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange Detected- Added a government-operating-status notice and a link to official sources; - Updated software version from v3.1.0 to v3.2.0; - Removed the old version reference.SummaryDifference11%
- Check22 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to core content or functionality based on the provided additions/deletions.SummaryDifference0.3%
- Check36 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the Back to Top element was removed. No other substantive changes.SummaryDifference0.7%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.7%
- Check51 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference24%
- Check65 days agoChange DetectedThe page has updated its status from 'Recruiting' to 'Active, not recruiting' and has changed the revision number from v2.16.11 to v2.16.12. Additionally, the date has been updated from 2025-02-06 to 2025-08-13.SummaryDifference2%
Stay in the know with updates to Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inotuzumab Ozogamicin for B-ALL MRD+ Clinical Trial page.